These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10351146)

  • 1. NBA/NBS perspective on nvCJD.
    Wallington T
    Transfus Sci; 1998 Dec; 19(4):329-30. PubMed ID: 10351146
    [No Abstract]   [Full Text] [Related]  

  • 2. The risk of transmission of nvCJD by blood transfusion and the potential benefits of leucodepletion.
    Turner M
    Transfus Sci; 1998 Dec; 19(4):331-2. PubMed ID: 10351147
    [No Abstract]   [Full Text] [Related]  

  • 3. International views on universal leucodepletion: the perspective in NBS, England.
    Wallington T
    Transfus Sci; 1998 Dec; 19(4):347-8. PubMed ID: 10351150
    [No Abstract]   [Full Text] [Related]  

  • 4. International views on universal leucodepletion: the perspective in Germany.
    Seitz MD
    Transfus Sci; 1998 Dec; 19(4):359-60. PubMed ID: 10351155
    [No Abstract]   [Full Text] [Related]  

  • 5. Universal leucodepletion--practical and regulatory consequences.
    Barrowcliffe TW
    Transfus Sci; 1998 Dec; 19(4):361. PubMed ID: 10351156
    [No Abstract]   [Full Text] [Related]  

  • 6. International views on universal leucodepletion: the perspective in NBS, Ireland.
    Murphy W
    Transfus Sci; 1998 Dec; 19(4):349-50. PubMed ID: 10351151
    [No Abstract]   [Full Text] [Related]  

  • 7. International views on universal leucodepletion: the perspective in Portugal.
    de Sousa G
    Transfus Sci; 1998 Dec; 19(4):351-2. PubMed ID: 10351152
    [No Abstract]   [Full Text] [Related]  

  • 8. Logistical problems of supplying leucodepleted blood components within the national blood service.
    Tandy N
    Transfus Sci; 1998 Dec; 19(4):373-4. PubMed ID: 10351160
    [No Abstract]   [Full Text] [Related]  

  • 9. Perspective on Nordic views on selective/universal leukodepletion.
    Flesland O
    Transfus Sci; 1998 Dec; 19(4):355-7. PubMed ID: 10351154
    [No Abstract]   [Full Text] [Related]  

  • 10. Operational and research approaches to universal leucodepletion in Scotland.
    Prowse C
    Transfus Sci; 1998 Dec; 19(4):367-9. PubMed ID: 10351158
    [No Abstract]   [Full Text] [Related]  

  • 11. Validation approaches selective/universal leucodepletion: the need for standardised validation strategies.
    Seghatchian MJ; Krailadsiri P
    Transfus Sci; 1998 Dec; 19(4):363-5. PubMed ID: 10351157
    [No Abstract]   [Full Text] [Related]  

  • 12. NBS approaches to the approval of suppliers of leucodepletion systems.
    Smith KJ
    Transfus Sci; 1998 Dec; 19(4):371-2. PubMed ID: 10351159
    [No Abstract]   [Full Text] [Related]  

  • 13. A matter for debate: the risk of bovine spongiform encephalopathy to humans posed by blood transfusion in the UK.
    Dealler S
    Transfus Med; 1996 Sep; 6(3):217-22. PubMed ID: 8885150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creutzfeldt-Jakob disease and the risk from blood or blood products.
    Will RG; Kimberlin RH
    Vox Sang; 1998; 75(3):178-80. PubMed ID: 9852403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bovine spongiform encephalopathy in ruminants and the new variant of Creutzfeldt-Jakob disease in humans].
    Groschup MH
    Dtsch Tierarztl Wochenschr; 1999 Aug; 106(8):329-31. PubMed ID: 10488637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential clinical benefits and cost savings of universal leucocyte-depletion of blood components.
    Murphy MF
    Transfus Sci; 1998 Dec; 19(4):343-6. PubMed ID: 10351149
    [No Abstract]   [Full Text] [Related]  

  • 17. Lessons from the response to the threat of transfusion-transmitted vCJD in Ireland.
    Murphy WG
    Transfus Clin Biol; 2013 Sep; 20(4):416-21. PubMed ID: 24001606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. British study will assess risks of vCJD blood transmission.
    Butler D
    Nature; 1997 Nov; 390(6656):105. PubMed ID: 9367139
    [No Abstract]   [Full Text] [Related]  

  • 19. From the Centers for Disease Control and Prevention. World Health Organization Consultation on public health issues related to bovine spongiform encephalopathy and the emergence of a new variant of Creutzfeldt-Jakob disease.
    JAMA; 1996 May; 275(17):1305-6. PubMed ID: 8614103
    [No Abstract]   [Full Text] [Related]  

  • 20. Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: implications for physicians.
    MacKnight C; Rockwood K
    CMAJ; 1996 Sep; 155(5):529-36. PubMed ID: 8804258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.